Iron and manganese-related CNS toxicity

mechanisms, diagnosis and treatment

Pan Chen, Melissa Totten, Ziyan Zhang, Hana Bucinca, Keith Erikson, Abel Santamaría, Aaron B. Bowman, Michael Aschner

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: Iron (Fe) and manganese (Mn) are essential nutrients for humans. They act as cofactors for a variety of enzymes. In the central nervous system (CNS), these two metals are involved in diverse neurological activities. Dyshomeostasis may interfere with the critical enzymatic activities, hence altering the neurophysiological status and resulting in neurological diseases. Areas covered: In this review, the authors cover the molecular mechanisms of Fe/Mn-induced toxicity and neurological diseases, as well as the diagnosis and potential treatment. Given that both Fe and Mn are abundant in the earth crust, nutritional deficiency is rare. In this review the authors focus on the neurological disorders associated with Mn and Fe overload. Expert commentary: Oxidative stress and mitochondrial dysfunction are the primary molecular mechanism that mediates Fe/Mn-induced neurotoxicity. Although increased Fe or Mn concentrations have been found in brain of patients, it remains controversial whether the elevated metal amounts are the primary cause or secondary consequence of neurological diseases. Currently, treatments are far from satisfactory, although chelation therapy can significantly decrease brain Fe and Mn levels. Studies to determine the primary cause and establish the molecular mechanism of toxicity may help to adapt more comprehensive and satisfactory treatments in the future.

Original languageEnglish (US)
Pages (from-to)243-260
Number of pages18
JournalExpert Review of Neurotherapeutics
Volume19
Issue number3
DOIs
StatePublished - Mar 4 2019

Fingerprint

Manganese
Iron
Central Nervous System
Therapeutics
Metals
Chelation Therapy
Brain
Nervous System Diseases
Malnutrition
Oxidative Stress
Food
Enzymes

Keywords

  • CNS diseases
  • Iron
  • manganese
  • neurotoxicity

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Iron and manganese-related CNS toxicity : mechanisms, diagnosis and treatment. / Chen, Pan; Totten, Melissa; Zhang, Ziyan; Bucinca, Hana; Erikson, Keith; Santamaría, Abel; Bowman, Aaron B.; Aschner, Michael.

In: Expert Review of Neurotherapeutics, Vol. 19, No. 3, 04.03.2019, p. 243-260.

Research output: Contribution to journalReview article

Chen, Pan ; Totten, Melissa ; Zhang, Ziyan ; Bucinca, Hana ; Erikson, Keith ; Santamaría, Abel ; Bowman, Aaron B. ; Aschner, Michael. / Iron and manganese-related CNS toxicity : mechanisms, diagnosis and treatment. In: Expert Review of Neurotherapeutics. 2019 ; Vol. 19, No. 3. pp. 243-260.
@article{2d01115218ea488cbb7b2ee2d87e0c32,
title = "Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment",
abstract = "Introduction: Iron (Fe) and manganese (Mn) are essential nutrients for humans. They act as cofactors for a variety of enzymes. In the central nervous system (CNS), these two metals are involved in diverse neurological activities. Dyshomeostasis may interfere with the critical enzymatic activities, hence altering the neurophysiological status and resulting in neurological diseases. Areas covered: In this review, the authors cover the molecular mechanisms of Fe/Mn-induced toxicity and neurological diseases, as well as the diagnosis and potential treatment. Given that both Fe and Mn are abundant in the earth crust, nutritional deficiency is rare. In this review the authors focus on the neurological disorders associated with Mn and Fe overload. Expert commentary: Oxidative stress and mitochondrial dysfunction are the primary molecular mechanism that mediates Fe/Mn-induced neurotoxicity. Although increased Fe or Mn concentrations have been found in brain of patients, it remains controversial whether the elevated metal amounts are the primary cause or secondary consequence of neurological diseases. Currently, treatments are far from satisfactory, although chelation therapy can significantly decrease brain Fe and Mn levels. Studies to determine the primary cause and establish the molecular mechanism of toxicity may help to adapt more comprehensive and satisfactory treatments in the future.",
keywords = "CNS diseases, Iron, manganese, neurotoxicity",
author = "Pan Chen and Melissa Totten and Ziyan Zhang and Hana Bucinca and Keith Erikson and Abel Santamar{\'i}a and Bowman, {Aaron B.} and Michael Aschner",
year = "2019",
month = "3",
day = "4",
doi = "10.1080/14737175.2019.1581608",
language = "English (US)",
volume = "19",
pages = "243--260",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Iron and manganese-related CNS toxicity

T2 - mechanisms, diagnosis and treatment

AU - Chen, Pan

AU - Totten, Melissa

AU - Zhang, Ziyan

AU - Bucinca, Hana

AU - Erikson, Keith

AU - Santamaría, Abel

AU - Bowman, Aaron B.

AU - Aschner, Michael

PY - 2019/3/4

Y1 - 2019/3/4

N2 - Introduction: Iron (Fe) and manganese (Mn) are essential nutrients for humans. They act as cofactors for a variety of enzymes. In the central nervous system (CNS), these two metals are involved in diverse neurological activities. Dyshomeostasis may interfere with the critical enzymatic activities, hence altering the neurophysiological status and resulting in neurological diseases. Areas covered: In this review, the authors cover the molecular mechanisms of Fe/Mn-induced toxicity and neurological diseases, as well as the diagnosis and potential treatment. Given that both Fe and Mn are abundant in the earth crust, nutritional deficiency is rare. In this review the authors focus on the neurological disorders associated with Mn and Fe overload. Expert commentary: Oxidative stress and mitochondrial dysfunction are the primary molecular mechanism that mediates Fe/Mn-induced neurotoxicity. Although increased Fe or Mn concentrations have been found in brain of patients, it remains controversial whether the elevated metal amounts are the primary cause or secondary consequence of neurological diseases. Currently, treatments are far from satisfactory, although chelation therapy can significantly decrease brain Fe and Mn levels. Studies to determine the primary cause and establish the molecular mechanism of toxicity may help to adapt more comprehensive and satisfactory treatments in the future.

AB - Introduction: Iron (Fe) and manganese (Mn) are essential nutrients for humans. They act as cofactors for a variety of enzymes. In the central nervous system (CNS), these two metals are involved in diverse neurological activities. Dyshomeostasis may interfere with the critical enzymatic activities, hence altering the neurophysiological status and resulting in neurological diseases. Areas covered: In this review, the authors cover the molecular mechanisms of Fe/Mn-induced toxicity and neurological diseases, as well as the diagnosis and potential treatment. Given that both Fe and Mn are abundant in the earth crust, nutritional deficiency is rare. In this review the authors focus on the neurological disorders associated with Mn and Fe overload. Expert commentary: Oxidative stress and mitochondrial dysfunction are the primary molecular mechanism that mediates Fe/Mn-induced neurotoxicity. Although increased Fe or Mn concentrations have been found in brain of patients, it remains controversial whether the elevated metal amounts are the primary cause or secondary consequence of neurological diseases. Currently, treatments are far from satisfactory, although chelation therapy can significantly decrease brain Fe and Mn levels. Studies to determine the primary cause and establish the molecular mechanism of toxicity may help to adapt more comprehensive and satisfactory treatments in the future.

KW - CNS diseases

KW - Iron

KW - manganese

KW - neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=85063065108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063065108&partnerID=8YFLogxK

U2 - 10.1080/14737175.2019.1581608

DO - 10.1080/14737175.2019.1581608

M3 - Review article

VL - 19

SP - 243

EP - 260

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 3

ER -